Second Regular Session | 74th General Assembly
Colorado General AssemblyPresented to the Joint Health Committee.
This memorandum provides an overview of the sentencing categories in state law for felony and misdemeanor offenses, including special offender sentencing. The memorandum also explains the sentencing scheme for drug offenses and for habitual offenders. There are two appendices that accompany...
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its August 22, 2017, meeting.
Recent federal policy changes have increased public awareness of asset forfeiture, a process through which a law enforcement agency can seize property that may have been involved in a criminal action. While federal policy affects federal seizures in the state, Colorado law governs how state and...
This memorandum provides information concerning the use of capital punishment in Colorado and across the country. The memorandum provides a brief history of Colorado’s death penalty scheme and information on recent U.S. Supreme Court decisions concerning the constitutionality of the death...
The rise in distracted driving, often associated with ever-present smart phones and mobile devices, has been identified as a cause and contributing factor to automobile crashes. This issue brief gives an overview of state and federal regulations on the issue.
This memorandum provides an overview of the County Courthouse and County Jail Funding and Overcrowding Solutions Interim Study Committee, including the charge of the committee, the committee membership, the bill limits, the bill request deadlines applicable to the committee, and information...
This memorandum provides an overview of county jails, including their function, population served, cost per day, and relationship with the state Department of Corrections.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.